Stock Analysis
Semperit Holding Second Quarter 2024 Earnings: EPS: €0.22 (vs €0.48 in 2Q 2023)
Semperit Holding (VIE:SEM) Second Quarter 2024 Results
Key Financial Results
- Revenue: €170.5m (down 10% from 2Q 2023).
- Net income: €4.53m (down 53% from 2Q 2023).
- Profit margin: 2.7% (down from 5.1% in 2Q 2023). The decrease in margin was driven by lower revenue.
- EPS: €0.22 (down from €0.48 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Semperit Holding Earnings Insights
Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Machinery industry in Europe.
Performance of the market in Austria.
The company's shares are up 7.4% from a week ago.
Risk Analysis
We should say that we've discovered 3 warning signs for Semperit Holding that you should be aware of before investing here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About WBAG:SEM
Semperit Holding
Develops, produces, and sells rubber products for the medical and industrial sectors worldwide.